BY-170424

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameBY-170424
Drug Alias NameBY-424
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHelicobacter Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNycomed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNycomed
Active IndicationsN/A
Inactive IndicationsHelicobacter Infections

Other Information

ATC CodeN/A
Related LinksN/A